Antitrust M&A
Weil has an impressive track record of obtaining global antitrust clearance in “bet-the-company” mergers, acquisitions and joint ventures, oftentimes in highly complex matters and industries facing heightened scrutiny.
Notable Representations, Key Contacts
We have extensive experience with the key global antitrust agencies including the U.S. Federal Trade Commission, the U.S. Department of Justice, the European Commission, and the UK Competition and Markets Authority. Our team includes a number of former senior U.S. and European government officials in our ranks. This deep bench and expertise gives us unmatched insight into how merger cases are analyzed, investigated, and litigated. We bring this perspective to bear in devising creative and successful deal strategies to minimize risks and delays for our clients, from initial risk assessment through to clearance.
As a result, Weil has an unparalleled track record of:
- Winning agency merger court challenges in U.S. courts.
- Leading the way on getting complex Phase 1 remedies cases over the line where, in recent times, we have consistently represented the merging parties on Phase 1 remedies cases approved by the EC.
- Advising on the most significant Phase 2 cases and securing clearance via innovative and ambitious remedies proposals, including the first UK fast-track Phase 2 remedies case that the CMA has approved since the procedure’s introduction in 2021.
Weil is consistently trusted by clients to handle multi-jurisdictional merger reviews and ensure swift approvals, with expert lawyers located in the United States and throughout Europe. In countries where Weil does not have offices, we have developed collaborative relationships with the best local law firms to ensure best-in-class service and an efficient process no matter the jurisdiction.
We also have significant expertise in the rapidly evolving foreign direct investment controls globally. We are trusted by clients to assess and successfully address the shifting regulatory risks associated with their cross-border investments, and to provide an efficient and transparent single point of contact for handling foreign investment control and merger control filings.
Client Recognition
50
Select Representations
Johnson & Johnson
Meta Platforms
Sanofi
Microsoft
MGM Resorts International
Walgreens Boots Alliance
Charles River Laboratories
Eutelsat
Maxim Integrated Products
Nets A/S and Nexi SpA
Sherwin Williams
Core-Mark Holding Company, Inc.
Liberty Global and Telefonica
Booking Holdings
Macquarie Asset Management
Generation Investment Management
Key Contacts
Shortcut Links
Awards and Recognition, Speaking Engagements, Latest Thinking, Firm News & Announcements
Awards and Recognition
- Weil Recognized in Global Competition Review's Matter of the Year for 2019 Award Brief — Global Competition Review Awards
- Weil Named “Antitrust Firm of the Year” Award Brief — Legal Media Group’s Sixth Annual Life Sciences Awards, 2018
- Jeff White Named 2018 Rising Star for Antitrust/Competition by Law360 Award Brief — Law360 2018
- Weil’s Antitrust Practice Ranked Among the “Global Elite” in 2018 Award Brief — Global Competition Review, GCR 100 2018
- Weil Named 2017 Competition Practice Group of the Year Award Brief — Law360 2017
- Weil’s Counsel to Allergan Wins “Merger Control Matter of the Year” for the Americas Award Brief — Global Competition Review Awards 2017
Speaking Engagements
-
Novel Theories of How Mergers Harm Competition
Speaker(s):
Megan A. Granger
November 14, 2023 — Weil Antitrust partner Megan Granger participated on a panel at Global Competition Review’s 2023 Women in Antitrust conference entitled “Novel Theories of How Mergers Harm Competition”. The panel discussed the increased evaluation of mergers by global competition authorities under new theories about how they are likely to lessen competition.
-
Unlocking Antitrust – Updates on Merger Enforcement
Speaker(s):
Carla A. R. Hine
November 1, 2023 — Weil Antitrust counsel Carla Hine served as a panelist at an event hosted by the NYU Law School Antitrust & Competition Law Society and the NYU Center on Civil Justice to discuss the state and direction of US merger law and enforcement.
Latest Thinking
- FTC and DOJ Announce Final Rulemaking for Overhaul of HSR Premerger Notification Filings and Reinstate Early Termination Alert — Antitrust — By Brianne Kucerik, Jeffrey H. Perry, Michael Moiseyev, Carla A. R. Hine, Michael C. Naughton, Marie-Marie O. de Fays and Dan S. Nobil — PDF — October 11, 2024
- U.S. Federal Trade Commission and Department of Justice Antitrust Division Finalize Joint Merger Guidelines Alert — Antitrust — By Michael Moiseyev, Kristin Sanford, John E. Scribner, Anne Corbett and Geneva Torsilieri Hardesty — PDF — January 08, 2024
- Let’s Keep Talking: Major UK Merger Procedural Reforms Promise Better Engagement And Transparency For Complex Deals Alert — Antitrust — By Jenine Hulsmann, Nafees Saeed, Bella Spring, Jenny Patroclou and Hannah Bannister — PDF — December 2023
- To Earn Trust, Climate Alliances Need to Improve Transparency Publication — Harvard Business Review — By Chris Chapman and Chris Thomas — November 29, 2023
- FTC Challenges Alleged “Roll Up” and Other Anticompetitive Conduct by Sponsor and Portfolio Company Alert — Antitrust — By Adam C. Hemlock, Megan A. Granger and Katya Dajani — PDF — September 28, 2023
Firm News & Announcements
- Weil Gains Global Elite Ranking in the GCR 100 2024 Firm Announcement — December 18, 2023
- Weil Is Advising General Atlantic on Its Investment in the Permira and Blackstone-Led Take-Private of Oslo-Listed Adevinta Deal Brief — November 27, 2023
- Weil Elects 16 New Partners and Announces New Counsel Class Firm Announcement — November 21, 2023